Principal Financial Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.55M | Sell |
|
|||||
|
2025
Q2 | $2.74M | Buy |
|
|||||
|
2025
Q1 | $2.63M | Buy |
|
|||||
|
2024
Q4 | $3.92M | Buy |
|
|||||
|
2024
Q3 | $3.91M | Sell |
|
|||||
|
2024
Q2 | $4.18M | Sell |
|
|||||
|
2024
Q1 | $5.47M | Sell |
|
|||||
|
2023
Q4 | $6.36M | Buy |
|
|||||
|
2023
Q3 | $5.91M | Buy |
|
|||||
|
2023
Q2 | $6.66M | Buy |
|
|||||
|
2023
Q1 | $5.92M | Sell |
|
|||||
|
2022
Q4 | $6.8M | Sell |
|
|||||
|
2022
Q3 | $8.93M | Buy |
|
|||||
|
2022
Q2 | $8.41M | Buy |
|
|||||
|
2022
Q1 | $262K | Sell |
|
|||||
|
2021
Q4 | $347K | Sell |
|
|||||
|
2021
Q3 | $491K | Sell |
|
|||||
|
2021
Q2 | $449K | Sell |
|
|||||
|
2021
Q1 | $657K | Sell |
|
|||||
|
2020
Q4 | $625K | Buy |
|